Company Filing History:
Years Active: 2006
Title: Jun Wu - Innovator in Lymphocyte Activation Modulation
Introduction
Jun Wu is a notable inventor based in Sunnyvale, CA (US). He has made significant contributions to the field of immunology, particularly in the regulation of lymphocyte activation. His work has implications for both diagnosis and therapy related to immune responses.
Latest Patents
Jun Wu holds a patent for "PAK2: modulators of lymphocyte activation." This invention focuses on the regulation of lymphocyte activation through nucleic acids encoding PAK2. The patent outlines methods for identifying and utilizing various agents, including small organic molecules, peptides, and ribozymes, that can modulate lymphocyte activation via PAK2. This innovation is crucial for developing therapeutic strategies aimed at immune modulation.
Career Highlights
Jun Wu is currently associated with Rigel Pharmaceuticals, Incorporated, where he continues to advance research in immunology. His expertise in lymphocyte activation has positioned him as a key figure in the development of new therapeutic approaches.
Collaborations
Some of his notable coworkers include X Charlene Liao and Peter Chu. Their collaborative efforts contribute to the innovative research environment at Rigel Pharmaceuticals.
Conclusion
Jun Wu's work in lymphocyte activation modulation represents a significant advancement in immunology. His patent and ongoing research have the potential to impact therapeutic strategies for immune-related conditions.